Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Times Interest Earned (2016 - 2026)

Ironwood Pharmaceuticals' Times Interest Earned history spans 16 years, with the latest figure at -$9.76 for Q4 2025.

  • On a quarterly basis, Times Interest Earned fell 376.36% to -$9.76 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.45, a 84.07% decrease, with the full-year FY2025 number at $0.45, down 84.07% from a year prior.
  • Times Interest Earned hit -$9.76 in Q4 2025 for Ironwood Pharmaceuticals, down from $8.95 in the prior quarter.
  • Over the last five years, Times Interest Earned for IRWD hit a ceiling of $93.07 in Q4 2023 and a floor of -$588.66 in Q2 2023.
  • Historically, Times Interest Earned has averaged -$14.72 across 5 years, with a median of $5.69 in 2025.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 440.57% in 2022 and later plummeted 2434.34% in 2023.
  • Tracing IRWD's Times Interest Earned over 5 years: stood at -$16.79 in 2021, then skyrocketed by 366.76% to $44.8 in 2022, then skyrocketed by 107.75% to $93.07 in 2023, then tumbled by 96.2% to $3.53 in 2024, then crashed by 376.36% to -$9.76 in 2025.
  • Business Quant data shows Times Interest Earned for IRWD at -$9.76 in Q4 2025, $8.95 in Q3 2025, and $5.42 in Q2 2025.